ArticlePharmaceutical biology2021

Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia.

Rubin Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.